Mehanna, H., & Gray, A. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial. Elsevier.
Chicago Style (17th ed.) CitationMehanna, H., and A. Gray. Radiotherapy Plus Cisplatin or Cetuximab in Low-risk Human Papillomavirus-positive Oropharyngeal Cancer (De-ESCALaTE HPV): An Open-label Randomised Controlled Phase 3 Trial. Elsevier, 2019.
MLA (9th ed.) CitationMehanna, H., and A. Gray. Radiotherapy Plus Cisplatin or Cetuximab in Low-risk Human Papillomavirus-positive Oropharyngeal Cancer (De-ESCALaTE HPV): An Open-label Randomised Controlled Phase 3 Trial. Elsevier, 2019.
Warning: These citations may not always be 100% accurate.